Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common stock, $0.001 par value
-
Shares outstanding
-
78.8M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
9.26M
-
Shares change
-
+935K
-
Total reported value, excl. options
-
$68.8M
-
Value change
-
+$7.24M
-
Put/Call ratio
-
1.96
-
Number of buys
-
40
-
Number of sells
-
-18
-
Price
-
$7.43
Significant Holders of CorMedix Inc. - Common stock, $0.001 par value (CRMD) as of Q4 2020
86 filings reported holding CRMD - CorMedix Inc. - Common stock, $0.001 par value as of Q4 2020.
CorMedix Inc. - Common stock, $0.001 par value (CRMD) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.26M shares
of 78.8M outstanding shares and own 11.76% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2M shares), Elliott Investment Management L.P. (1.76M shares), VANGUARD GROUP INC (1.35M shares), STATE STREET CORP (546K shares), GEODE CAPITAL MANAGEMENT, LLC (460K shares), NORTHERN TRUST CORP (353K shares), Cresset Asset Management, LLC (330K shares), TWO SIGMA ADVISERS, LP (214K shares), Nuveen Asset Management, LLC (214K shares), and TWO SIGMA INVESTMENTS, LP (152K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.